International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)

BACKGROUND: Real-world data on non-vitamin K oral anticoagulants (NOACs) are essential in determining whether evidence from randomised controlled clinical trials translate into meaningful clinical benefits for patients in everyday practice. RIVER (RIVaroxaban Evaluation in Real life setting) is an o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thromb J
Autores principales: Beyer-Westendorf, Jan, Camm, A. John, Fox, Keith A. A., Le Heuzey, Jean-Yves, Haas, Sylvia, Turpie, Alexander G. G., Virdone, Saverio, Kakkar, Ajay K.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482585/
https://ncbi.nlm.nih.gov/pubmed/31169831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-019-0195-7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares